"USP Chapter 797: Understanding the Revisions” Technical Paper By Baxa Corporation’s Mike Hurst Now Accessible on Expert411.com For Media and Professional Reference

(PRLEAP.COM) The “USP Chapter 797: Understanding the Revisions” technical paper, authored by Baxa Corporation’s Mike Hurst, RPh, MBA, is now accessible at Expert411.com for media and professional reference. USP Chapter 797 became official on January 1, 2004 The first major revision was released on December 3, 2007, following years of soliciting feedback and the review of hundreds of responses by the USP Sterile Compounding Committee. June 1, 2008, is the effective date for the new standards. This paper summarizes the most important changes to USP 797.

Englewood, CO – The “USP Chapter 797: Understanding the Revisions” technical paper, authored by Baxa Corporation’s Mike Hurst RPh, MBA, is now accessible at Expert411.com for media and professional reference. USP Chapter 797 became official on January 1, 2004. The first major revision was released on December 3, 2007, following years of soliciting feedback and the review of hundreds of responses by the USP Sterile Compounding Committee. June 1, 2008, is the effective date for the new standards. This paper summarizes the most important changes to USP 797.

This technical paper and links to ten other related publications are now available along with Hurst’s Expert Profile information at http://expert411.com/_wsn/page3.html

Other topics include:

* Overview of USP 797: Pharmaceutical Compounding – Sterile Preparations
* Oral Medication Dispensers in Clinical Research
* Enteral Feeding Misconnections
* Environmental Controls for Sterile Compounding
* The Limitations of Isolators
* Pharmacy Considerations for Syringe Batch Processing
* Safe Handling of Hazardous Drugs
* USP 797 Requirements for Automated Compounders
* Technical Bulletin for Risk Level Assessment
* Outsourcing for USP 797

Hurst worked for 18 years at Swedish Medical Center in Seattle, Washington in operational management, including positions as IV Supervisor and Assistant Director of Pharmacy. Moving to industry full time in 1994, Hurst joined Baxa Corporation as Vice President of Infusion Systems.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Further information is available at http://www.baxa.com

Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com
http://www.baxa.com

Maggie Chamberlin Holben, APR, Absolutely Public Relations
303.984.9801, 303.669.3558
Email: maggie@absolutelypr.com
http://www.absolutelypr.com

PR Leap is a service of Condesa, Inc. © 2009 All Rights Reserved. Use of our service is governed by our Privacy Policy and Terms of Service.
Issuers of news releases are solely responsible for the accuracy of their content. Copyright / IP Policy